Pharsight

Application	Filing Date	Opposition Party	Legal Status

EP02782404A	2014-06-04	Laboratorios Léon Farma, S.A.	Revoked
EP02782404A	2014-06-03	Bröcher, Dirk Joachim	Revoked

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545	TEVA BRANDED PHARM	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology	Jun, 2023 (3 months ago)
US7858605	TEVA BRANDED PHARM	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology	Jun, 2023 (3 months ago)
US7320969	TEVA BRANDED PHARM	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology	Jan, 2024 (3 months from now)
US7855190	TEVA BRANDED PHARM	Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration	Dec, 2028 (5 years from now)

Seasonique is owned by Teva Branded Pharm.

Seasonique contains Ethinyl Estradiol; Levonorgestrel.

Seasonique has a total of 4 drug patents out of which 2 drug patents have expired.

Expired drug patents of Seasonique are:

US7615545
US7858605

Seasonique was authorised for market use on 25 May, 2006.

Seasonique is available in tablet;oral dosage forms.

Seasonique can be used as prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception, prevention of pregnancy.

The generics of Seasonique are possible to be released after 05 December, 2028.

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 25 May, 2006

Treatment: Prevention of pregnancy; Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL